A share price of Semler Scientific Inc [SMLR] is currently trading at $29.49, up 6.54%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SMLR shares have gain 3.33% over the last week, with a monthly amount drifted -7.51%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, The Benchmark Company started tracking the stock with Buy rating on July 08, 2025, and set its price target to $101. On November 02, 2022, downgrade downgraded it’s rating to Neutral and revised its price target to $45 on the stock.
Semler Scientific Inc experienced fluctuations in its stock price throughout the past year between $21.77 and $81.56. Currently, Wall Street analysts expect the stock to reach $61 within the next 12 months. Semler Scientific Inc [NASDAQ: SMLR] shares were valued at $29.49 at the most recent close of the market. An investor can expect a potential return of 106.85% based on the average SMLR price forecast.
Analyzing the SMLR fundamentals
Trailing Twelve Months sales for Semler Scientific Inc [NASDAQ:SMLR] were 42.98M which represents -43.19% decline. Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -0.57%, Pretax Profit Margin comes in at 1.04%, and Net Profit Margin reading is 0.86%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.17 and Total Capital is -0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Semler Scientific Inc [NASDAQ:SMLR] is 0.60. As well, the Quick Ratio is 0.58, while the Cash Ratio is 0.37. Considering the valuation of this stock, the price to sales ratio is 10.16, the price to book ratio is 1.05 and price to earnings (TTM) ratio is 12.15.
Transactions by insiders
Recent insider trading involved Murphy-Chutorian Douglas, Chief Executive Officer, that happened on Aug 25 ’25 when 28604.0 shares were sold. CEO, Douglas Murphy-Chutorian completed a deal on Aug 25 ’25 to buy 60000.0 shares. Meanwhile, CEO Murphy-Chutorian Douglas sold 75000.0 shares on Dec 10 ’24.
